The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Our earlier studies have demonstrated that (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid ACPT-I, a group III mGlu receptor agonist, produced anxiolytic-like and antidepressant-like actions after central administration. Here we describe the anxiolytic-like effects of ACPT-I after intraperitoneal administration in the stress-induced hyperthermia (SIH), elevated plus-maze (PMT) tests in mice and in the Vogel test in rats. However, the compound did not produce antidepressant-like effects in the tail suspension test (TST) or in the forced swim test (FST) in mice. The potential anxiolytic effect of ACPT-I (20 mg/kg) in the SIH test was inhibited by the benzodiazepine receptor antagonist flumazenil (given i.p., 10 mg/kg), and by a 5-HT(1A) receptor antagonist N-{2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridynyl) cyclohexane-carboxamide (WAY100635) (0.1 mg/kg s.c.). At the same time, ritanserin (0.5 mg/kg i.p.), the 5-HT2A/C receptor antagonist, did not change the anxiolytic-like effects of ACPT-I. The results of these studies indicate that the GABA-ergic and serotonergic systems are involved in the potential anxiolytic action of ACPT-I.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors
Cartmell, J., & Schoepp, D. D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750889.x · Cited by 883 · cited 2×
“Group II and III mGlu receptors are mainly localized presynaptically (Schoepp, 2001) and serve as autoreceptors at brain structures (Gereau and Conn, 1995; Manzoni and Bockaert, 1995; Ugolini and Bordi, 1995; Cartmell and Schoepp, 2000).”
BackgroundIdentification of a serotonin/glutamate receptor complex implicated in psychosis
González-Maeso, J., Ang, R. L., Yuen, T., Chan, P., Weisstaub, N. V., López-Giménez, J. F., Zhou, M., Okawa, Y., Callado, L. F., Milligan, G., et al. (2008) · Nature · doi:10.1038/nature06612 · Cited by 803 · cited 1×
“, 2002) and recently, a complex of 5-HT2/mGlu2 receptors has been identified and implicated in psychosis (González-Maeso et al., 2008), nothing is known about interactions between mGlu and 5-HT1A receptors.”
BackgroundMetabotropic glutamate receptors as novel targets for anxiety and stress disorders
Swanson, C. J., Bures, M., Johnson, M. P., Linden, A.-M., Monn, J. A., & Schoepp, D. D. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1630 · Cited by 607
Serotonin model of schizophrenia: emerging role of glutamate mechanisms
Aghajanian, G. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00046-6 · Cited by 529
Gereau, R., & Conn, P. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06879.1995 · Cited by 352
Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety
Kent, J. M., Coplan, J. D., & Gorman, J. M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00210-8 · Cited by 196
Duvoisin, R. M., Zhang, C., Pfankuch, T. F., O'Connor, H., Gayet‐Primo, J., Quraishi, S., & Raber, J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04210.x · Cited by 102 · cited 1×
“Moreover, the mGlu8 receptor knockout mice exhibit an anxiety phenotype (Linden et al., 2002; Duvoisin et al., 2005; Robbins et al., 2007).”
Background
Cited by
Tests of unconditioned anxiety — Pitfalls and disappointments
Ennaceur, A. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.05.032 · Cited by 259
New perspectives in glutamate and anxiety
Riaza Bermudo-Soriano, C., Perez-Rodriguez, M. M., Vaquero-Lorenzo, C., & Baca-Garcia, E. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.010 · Cited by 207
Dogra, S., & Conn, P. J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108687 · Cited by 71
Dadkhah, T., Rahimi-Aliabadi, S., Jamshidi, J., Ghaedi, H., Taghavi, S., Shokraeian, P., Akhavan-Niaki, H., Tafakhori, A., Ohadi, M., & Darvish, H. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.10.008 · Cited by 26
Micheli, L., Ceccarelli, M., D'Andrea, G., Costanzi, M., Giacovazzo, G., Coccurello, R., Caruso, C., & Tirone, F. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.08.023 · Cited by 19
“, 2011), or also by treatment with chemical substances impacting on the serotonin (5HT) and GABA pathways (Santarelli et al., 2003; Stachowicz et al., 2009; Wang et al., 2008).”
Metadata
- Authors
- Stachowicz, K., Kłodzińska, A., Palucha-Poniewiera, A., Schann, S., Neuville, P., & Pilc, A.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 57
- Issue
- 3
- Pages
- 227-234
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2074056751
- Cited by
- 39
- References
- 7
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems. https://app.cochat.ai/papers/10.1016/j.neuropharm.2009.06.005
- The paper
- Stachowicz, K., Kłodzińska, A., Palucha-Poniewiera, A., Schann, S., Neuville, P., & Pilc, A. (2009). The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2009.06.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.